Abstract:Accumulating evidence suggests that spinal cord astrocytes play an important role in neuropathic pain sensitization by releasing astrocytic mediators (e.g. cytokines, chemokines and growth factors). However, it remains unclear how astrocytes control the release of astrocytic mediators and sustain late-phase neuropathic pain. Astrocytic connexin-43 (now known as GJ1) has been implicated in gap junction and hemichannel communication of cytosolic contents through the glial syncytia and to the extracellular space, respectively. Connexin-43 also plays an essential role in facilitating the development of neuropathic pain, yet the mechanism for this contribution remains unknown. In this study, we investigated whether nerve injury could upregulate connexin-43 to sustain late-phase neuropathic pain by releasing chemokine from spinal astrocytes. Chronic constriction injury elicited a persistent upregulation of connexin-43 in spinal astrocytes for >3 weeks. Spinal (intrathecal) injection of carbenoxolone (a non-selective hemichannel blocker) and selective connexin-43 blockers (connexin-43 mimetic peptides (43)Gap26 and (37,43)Gap27), as well as astroglial toxin but not microglial inhibitors, given 3 weeks after nerve injury, effectively reduced mechanical allodynia, a cardinal feature of late-phase neuropathic pain. In cultured astrocytes, TNF-α elicited marked release of the chemokine CXCL1, and the release was blocked by carbenoxolone, Gap26/Gap27, and connexin-43 small interfering RNA. TNF-α also increased connexin-43 expression and hemichannel activity, but not gap junction communication in astrocyte cultures prepared from cortices and spinal cords. Spinal injection of TNF-α-activated astrocytes was sufficient to induce persistent mechanical allodynia, and this allodynia was suppressed by CXCL1 neutralization, CXCL1 receptor (CXCR2) antagonist, and pretreatment of astrocytes with connexin-43 small interfering RNA. Furthermore, nerve injury persistently increased excitatory synaptic transmission (spontaneous excitatory postsynaptic currents) in spinal lamina IIo nociceptive synapses in the late phase, and this increase was suppressed by carbenoxolone and Gap27, and recapitulated by CXCL1. Together, our findings demonstrate a novel mechanism of astrocytic connexin-43 to enhance spinal cord synaptic transmission and maintain neuropathic pain in the late-phase via releasing chemokines.

Astrocyte-restricted disruption of connexin-43 impairs neuronal plasticity in mouse barrel cortex.

Glial Modulation of Vibrissal Sensory Processing in Rats.

Astroglial Connexin 43 Regulates Synaptic Vesicle Release at Hippocampal Synapses

Astrocytes Gate Long-Term Potentiation in Hippocampal Interneurons

Cortical astrocyte N-methyl-D-aspartate receptors influence whisker barrel activity and sensory discrimination in mice

Connexin 43 Deletion in Astrocytes Promotes CNS Remyelination by Modulating Local Inflammation

Connexin43 in Neonatal Excitatory Neurons is Important for Short-Term Motor Learning

Specific deletion connexin43 in astrocyte ameliorates cognitive dysfunction in APP/PS1 mice

Astroglial Connexin43 Hemichannels Tune Basal Excitatory Synaptic Transmission

Connexin Hemichannels in Astrocytes: Role in CNS Disorders

Abstract TP90: Disruption of Connexin30/32 Contributes to Impaired Oligodendrogenesis in Ischemic White Matter Injury

Connexin-43 Induces Chemokine Release from Spinal Cord Astrocytes to Maintain Late-Phase Neuropathic Pain in Mice

Astrocytic modulation of population encoding in mouse visual cortex via GABA transporter 3 revealed by multiplexed CRISPR/Cas9 gene editing

Connexin 43 regulates astrocyte dysfunction and cognitive deficits in early life stress-treated mice

Upregulation of astroglial connexin 30 impairs hippocampal synaptic activity and recognition memory

Connexin43 hemichannels contribute to working memory and excitatory synaptic transmission of pyramidal neurons in the prefrontal cortex of rats

Suppression of Connexin 43 Leads to Strial Vascular Hyper-Permeability, Decrease in Endocochlear Potential, and Mild Hearing Loss

New insights into the expression and function of neural connexins with transgenic mouse mutants

Astrocytic connexin 43 potentiates myelin injury in ischemic white matter disease

Requirement of Neuronal Connexin36 in Pathways Mediating Presynaptic Inhibition of Primary Afferents in Functionally Mature Mouse Spinal Cord